Literature DB >> 9686610

Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors.

Y Zhan1, C Cheers.   

Abstract

When mice were infected i.v. with either Listeria monocytogenes or Brucella abortus, bioactive IL-12 was briefly detected in serum and supernatants of spleen homogenates immediately ex vivo. Although the time scale was more prolonged for the more slowly growing B. abortus, in both instances IL-12 production ceased while bacteria still persisted in high numbers. Production of IL-12, detected in serum and spleen, was neither increased nor prolonged by injecting Abs to IL-10 or IL-4. In contrast with live organisms, heat-killed bacteria did not induce detectable IL-12 in vivo and were less efficient when added in vitro to resident peritoneal cells or spleen cells. Mice lacking the receptors for TNF (TNFR-/- mice) were severely deficient in IL-12 production, suggesting a controlling role for TNF, which we have previously shown to be triggered by live, rather than dead, bacteria. Infection in the TNFR-/- mice was exacerbated, although in the Brucella-infected mice splenomegaly, the main indicator of immunopathology, was reduced. Production of NO by macrophages was deficient, but the TNFR-/- mice were not deficient in IFN-gamma production. In addition to being poor inducers of IL-12, killed bacteria actively suppressed IL-12 production in response to live bacteria, by mechanism(s) unknown. The implications of these findings are discussed in light of the fact that only live bacteria satisfactorily induce cell-mediated immunity to infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686610

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages.

Authors:  V Jubier-Maurin; R A Boigegrain; A Cloeckaert; A Gross; M T Alvarez-Martinez; A Terraza; J Liautard; S Köhler; B Rouot; J Dornand; J P Liautard
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness.

Authors:  María P Jiménez de Bagüés; Antoine Gross; Annie Terraza; Jacques Dornand
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.

Authors:  Xinghong Yang; Beata Clapp; Theresa Thornburg; Carol Hoffman; David W Pascual
Journal:  Vaccine       Date:  2016-09-14       Impact factor: 3.641

4.  Evaluation of oxidative stress and inflammation in long term Brucella melitensis infection.

Authors:  Ismet M Melek; Suat Erdogan; Sefa Celik; Ozkan Aslantas; Taskin Duman
Journal:  Mol Cell Biochem       Date:  2006-06-30       Impact factor: 3.396

Review 5.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 6.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

7.  Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice.

Authors:  E A Murphy; J Sathiyaseelan; M A Parent; B Zou; C L Baldwin
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

8.  Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.

Authors:  Marco A Campos; Gracia M S Rosinha; Igor C Almeida; Xirlene S Salgueiro; Bruce W Jarvis; Gary A Splitter; Nilofer Qureshi; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio C Oliveira
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  TLR9 is required for MAPK/NF-κB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus.

Authors:  Marco Túlio Gomes; Priscila Carneiro Campos; Guilherme de Sousa Pereira; Daniella Castanheira Bartholomeu; Gary Splitter; Sergio Costa Oliveira
Journal:  J Leukoc Biol       Date:  2015-11-17       Impact factor: 4.962

10.  The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.

Authors:  Zhihe Kuang; Rowena S Lewis; Joan M Curtis; Yifan Zhan; Bernadette M Saunders; Jeffrey J Babon; Tatiana B Kolesnik; Andrew Low; Seth L Masters; Tracy A Willson; Lukasz Kedzierski; Shenggen Yao; Emanuela Handman; Raymond S Norton; Sandra E Nicholson
Journal:  J Cell Biol       Date:  2010-07-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.